IBDEI1RQ ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,29605,1,3,0)
 ;;=3^Malig Neop of Thyroid Gland
 ;;^UTILITY(U,$J,358.3,29605,1,4,0)
 ;;=4^C73.
 ;;^UTILITY(U,$J,358.3,29605,2)
 ;;=^267296
 ;;^UTILITY(U,$J,358.3,29606,0)
 ;;=E10.21^^135^1364^8
 ;;^UTILITY(U,$J,358.3,29606,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29606,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,29606,1,4,0)
 ;;=4^E10.21
 ;;^UTILITY(U,$J,358.3,29606,2)
 ;;=^5002589
 ;;^UTILITY(U,$J,358.3,29607,0)
 ;;=E10.9^^135^1364^12
 ;;^UTILITY(U,$J,358.3,29607,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29607,1,3,0)
 ;;=3^DM Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,29607,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,29607,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,29608,0)
 ;;=E11.21^^135^1364^17
 ;;^UTILITY(U,$J,358.3,29608,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29608,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,29608,1,4,0)
 ;;=4^E11.21
 ;;^UTILITY(U,$J,358.3,29608,2)
 ;;=^5002629
 ;;^UTILITY(U,$J,358.3,29609,0)
 ;;=E11.39^^135^1364^18
 ;;^UTILITY(U,$J,358.3,29609,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29609,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Ophthalmic Complication NEC
 ;;^UTILITY(U,$J,358.3,29609,1,4,0)
 ;;=4^E11.39
 ;;^UTILITY(U,$J,358.3,29609,2)
 ;;=^5002643
 ;;^UTILITY(U,$J,358.3,29610,0)
 ;;=E11.43^^135^1364^15
 ;;^UTILITY(U,$J,358.3,29610,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29610,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Autonomic Neuropathy
 ;;^UTILITY(U,$J,358.3,29610,1,4,0)
 ;;=4^E11.43
 ;;^UTILITY(U,$J,358.3,29610,2)
 ;;=^5002647
 ;;^UTILITY(U,$J,358.3,29611,0)
 ;;=E11.59^^135^1364^13
 ;;^UTILITY(U,$J,358.3,29611,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29611,1,3,0)
 ;;=3^DM Type 2 w/ Circulatory Complications NEC
 ;;^UTILITY(U,$J,358.3,29611,1,4,0)
 ;;=4^E11.59
 ;;^UTILITY(U,$J,358.3,29611,2)
 ;;=^5002652
 ;;^UTILITY(U,$J,358.3,29612,0)
 ;;=E11.618^^135^1364^14
 ;;^UTILITY(U,$J,358.3,29612,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29612,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Arthropathy NEC
 ;;^UTILITY(U,$J,358.3,29612,1,4,0)
 ;;=4^E11.618
 ;;^UTILITY(U,$J,358.3,29612,2)
 ;;=^5002654
 ;;^UTILITY(U,$J,358.3,29613,0)
 ;;=E11.621^^135^1364^16
 ;;^UTILITY(U,$J,358.3,29613,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29613,1,3,0)
 ;;=3^DM Type 2 w/ Diabetic Foot Ulcer
 ;;^UTILITY(U,$J,358.3,29613,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,29613,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,29614,0)
 ;;=E11.622^^135^1364^20
 ;;^UTILITY(U,$J,358.3,29614,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29614,1,3,0)
 ;;=3^DM Type 2 w/ Skin Ulcer NEC
 ;;^UTILITY(U,$J,358.3,29614,1,4,0)
 ;;=4^E11.622
 ;;^UTILITY(U,$J,358.3,29614,2)
 ;;=^5002657
 ;;^UTILITY(U,$J,358.3,29615,0)
 ;;=E11.65^^135^1364^19
 ;;^UTILITY(U,$J,358.3,29615,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29615,1,3,0)
 ;;=3^DM Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,29615,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,29615,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,29616,0)
 ;;=E11.9^^135^1364^21
 ;;^UTILITY(U,$J,358.3,29616,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29616,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,29616,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,29616,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,29617,0)
 ;;=E13.9^^135^1364^22
 ;;^UTILITY(U,$J,358.3,29617,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29617,1,3,0)
 ;;=3^Diabetes Mellitus (Secondary) w/o Complications NEC
 ;;^UTILITY(U,$J,358.3,29617,1,4,0)
 ;;=4^E13.9
 ;;^UTILITY(U,$J,358.3,29617,2)
 ;;=^5002704
 ;;^UTILITY(U,$J,358.3,29618,0)
 ;;=E16.2^^135^1364^29
